Comment on: Langerhans cell histiocytosis with BRAF p.N486_P490del or
MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib
06 Oct 2020Submission Checks Completed 06 Oct 2020Assigned to Editor
06 Oct 2020Submitted to Pediatric Blood & Cancer 07 Oct 2020Editorial Decision: Accept